Brian Hutchinson
Biographic Data
| ID | 6476314 |
|---|---|
| NAME | Brian Hutchinson |
| GIVEN NAMES | Brian |
| FAMILY NAME | Hutchinson |
| SIGNATURE | HUTCHINSON B |
| AFFILIATIONS | RTI International |
| ORCID | 0000-0002-5537-008X |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 20 |
| WORKS AS AUTHOR | 9 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2001 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
Current out of pocket care costs among HIV and hypertension co-morbid patients in urban and peri-urban Uganda
Background Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. This study aims to build evidence on the burden of current out-of-pocket costs of care among HIV-HTN co-morbi…
Advancing progress on tobacco control in low-income and middle-income countries through economic analysis
Tobacco control must be seen as more than a health concern. Tobacco control leads to economic benefits and contributes to sustainable development. National investment cases can support country ownership and leadership to advance tobacco control
Equity implications of tobacco taxation
Our results confirm that health benefits from increases in price through taxation are pro-poor. Even in countries where smoking prevalence is higher among wealthier groups, increasing prices can still be pro-poor due to variable responsiveness to higher prices. The costs associated with higher smoking prevalence among the poor, together with often limited access to healthcare services and displaced spending on basic needs, result in health inequa…
Interpreting results, impacts and implications from WHO FCTC tobacco control investment cases in 21 low-income and middle-income countries
WHO FCTC tobacco control measures would provide a positive return on investment in every country analysed
Evolving methodology of national tobacco control investment cases
Investment cases constitute a tool that development partners and advocates have demanded in even greater numbers. The economic argument for tobacco control provided by this set of country-contextualised analyses can be a strong tool for policy change
The case for investment in tobacco control
Objective. To synthesize learnings from four national tobacco control investment cases conducted in the Americas (Colombia, Costa Rica, El Salvador, Suriname) under the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) 2030 project, to describe results and how national health authorities have used the cases, and to discuss implications for the role of investment cases in advancing tobacco control. Methods. We draw on fi…
Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries
Generally, hypertension control programs are cost-effective, including in low- and middle-income countries, but country governments and civil society are not likely to support hypertension control programs unless value is demonstrated in terms of public health benefits, budget impact, and value-for-investment for the individual country context. The World Health Organization (WHO) and the Pan American Health Organization (PAHO) established a stand…
Assessing costs of a hypertension program in primary care
Objective. In 2021, Mexico launched the HEARTS program to improve the prevention and control of cardiovascular disease (CVD) risk factors in 20 primary care facilities in the states of Chiapas and Yucatán. This study projects the annual cost of program implementation and discusses budgetary implications for scaling up the program. Methods. We obtained district-level data on treatment protocols, medication costs, and other resources required to pr…
Health profiles of Hamilton
Health profiles of Hamilton
The case for investment in tobacco control
Objective. To synthesize learnings from four national tobacco control investment cases conducted in the Americas (Colombia, Costa Rica, El Salvador, Suriname) under the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) 2030 project, to describe results and how national health authorities have used the cases, and to discuss implications for the role of investment cases in advancing tobacco control. Methods. We draw on fi…
Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries
Generally, hypertension control programs are cost-effective, including in low- and middle-income countries, but country governments and civil society are not likely to support hypertension control programs unless value is demonstrated in terms of public health benefits, budget impact, and value-for-investment for the individual country context. The World Health Organization (WHO) and the Pan American Health Organization (PAHO) established a stand…
Assessing costs of a hypertension program in primary care
Objective. In 2021, Mexico launched the HEARTS program to improve the prevention and control of cardiovascular disease (CVD) risk factors in 20 primary care facilities in the states of Chiapas and Yucatán. This study projects the annual cost of program implementation and discusses budgetary implications for scaling up the program. Methods. We obtained district-level data on treatment protocols, medication costs, and other resources required to pr…
Current out of pocket care costs among HIV and hypertension co-morbid patients in urban and peri-urban Uganda
Background Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. This study aims to build evidence on the burden of current out-of-pocket costs of care among HIV-HTN co-morbi…
Advancing progress on tobacco control in low-income and middle-income countries through economic analysis
Tobacco control must be seen as more than a health concern. Tobacco control leads to economic benefits and contributes to sustainable development. National investment cases can support country ownership and leadership to advance tobacco control
Equity implications of tobacco taxation
Our results confirm that health benefits from increases in price through taxation are pro-poor. Even in countries where smoking prevalence is higher among wealthier groups, increasing prices can still be pro-poor due to variable responsiveness to higher prices. The costs associated with higher smoking prevalence among the poor, together with often limited access to healthcare services and displaced spending on basic needs, result in health inequa…
Interpreting results, impacts and implications from WHO FCTC tobacco control investment cases in 21 low-income and middle-income countries
WHO FCTC tobacco control measures would provide a positive return on investment in every country analysed
Evolving methodology of national tobacco control investment cases
Investment cases constitute a tool that development partners and advocates have demanded in even greater numbers. The economic argument for tobacco control provided by this set of country-contextualised analyses can be a strong tool for policy change
Medicine (9 works) · Business (8 works) · Public health (7 works) · Political science (6 works) · Geography (5 works) · Investment (military (5 works) · Tobacco control (5 works) · Economics (4 works) · Global Public Health Policies and Epidemiology (4 works) · Politics (4 works)